MetaADEDB 2.0 @ LMMD
Ceftizoxime
(NNULBSISHYWZJU-LLKWHZGFSA-N)
Structure
SMILES
CO/N=C(/c1csc(n1)N)\C(=O)N[C@H]1[C@H]2SCC=C(N2C1=O)C(=O)O
Type(s)
Approved; Investigational
ATC code(s)
J01DD07
Molecular Formula:
C13H13N5O5S2
Molecular Weight:
383.403
Log P:
0.3542
Hydrogen Bond Acceptor:
12
Hydrogen Bond Donor:
3
TPSA:
200.75
CAS Number(s):
68401-81-0
Synonym(s)
1.
Ceftizoxime
2.
Ceftizoxime Sodium
3.
Cefizox
4.
Ceftizoxime Monosodium Salt
5.
FK-749
6.
FK749
7.
FR-13749
8.
SK&F 88373-2
9.
SKF-88373
10.
FK 749
11.
FR 13749
12.
FR13749
13.
Monosodium Salt, Ceftizoxime
14.
SK&F 88373 2
15.
SK&F 883732
16.
SKF 88373
17.
SKF88373
18.
Salt, Ceftizoxime Monosodium
19.
Sodium, Ceftizoxime
External Link(s)
MeSHD015296
PubChem Compound6533629
BindingDB237182
ChEBI553473
CHEMBLCHEMBL528
DrugBankDB01332
DrugCentral563
KEGGcpd:C06890
dr:D07658
Therapeutic Target DatabaseD0Y7BD
ZINC3871970
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1ChillsFAERS: 9US FAERS
2Pharmaceutical product complaintFAERS: 6US FAERS
3CheilitisFAERS: 2US FAERS
4StomatitisFAERS: 2US FAERS
5Abdominal Pain3531567CTD
6AgranulocytosisSIDER
7Anaphylactic shockSIDER
8Anemia, Hemolytic20046091CTD
9ArthralgiaCanada Vigilance: 1Canada Vigilance
10Blood lactate dehydrogenase increasedSIDER
11CellulitisSIDER
12Coombs test positiveSIDER
13DermatitisSIDER
14Diarrhea3531567CTD
15Eosinophilia3531567CTD
SIDER
16Erythema MultiformeSIDER
17Haemophilus Infections3531567CTD
18HypersensitivitySIDER
19IndurationSIDER
20Injection site burningSIDER
21Injection site painSIDER
22Lactic dehydrogenase activity increasedSIDER
23LeukopeniaSIDER
24NauseaSIDER
25NeutropeniaSIDER
26NumbnessSIDER
27PainSIDER
28PancytopeniaSIDER
29PhlebitisSIDER
30PruritusSIDER
31Rash erythematousCanada Vigilance: 1Canada Vigilance
32Serum sickness-like reactionSIDER
33Stevens-Johnson SyndromeSIDER
34Streptococcal Infections3531567CTD
35ThrombocytopeniaSIDER
36Thrombocytosis3531567CTD
SIDER
37Toxic Epidermal NecrolysisSIDER
38UrticariaCanada Vigilance: 13531567CTD
Canada Vigilance
39VomitingSIDER
40pseudomembranous colitisSIDER
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120295

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.